Today’s non-acute healthcare providers are navigating an ever-complex operating environment. Workforce shortages, shifting care settings, and unpredictable supply chains are rewriting the norms for clinical teams and distributor partners alike. Sales representatives are now expected to provide not only products but also consistency, reliability, and innovative solutions that drive real results.
In response to these challenges, Dukal has established a new agreement with Provista, one of the nation’s leading group purchasing organizations (GPOs). Significantly expanding access to Dukal’s comprehensive portfolio of traditional and advanced wound care solutions – empowering Provista’s non-acute customer network.
For distributors, this partnership offers a strategic opportunity to enhance product alignment, improve standardization, and expand access to a contract-backed portfolio that is both clinically effective and operationally efficient.
Expanding High Value Solutions Across Non Acute Care
Through the new agreement, Provista members gain streamlined access to Dukal’s comprehensive traditional wound care offering:
- Gauze pads and sponges
- Adhesive bandages
- Elastic and cohesive bandages
- Medical tapes
- Primary and secondary dressings
- A complete range of cotton products
Foundational products are essential in physician offices, post-acute care settings, long-term care facilities, and home health organizations. Settings where product consistency and reliable supply directly impact staff efficiency and the quality of patient care. As budgets become more constrained and patient volumes fluctuate, sourcing a wide range of high-quality wound care essentials from a single, trusted manufacturer provides significant operational value.
For distributor sales teams, the contract streamlines discussions regarding standardization, alignment, and long-term planning, strengthening customer confidence in both product performance and supply continuity.
Advancing Care Through Innovative Wound Management Solutions
The agreement further extends Provista member access to Dukal’s advanced wound care solutions with the inclusion of RENCURA™ Silicone Bordered Foam Dressings. The RENCURA™ line is designed to support healing across the continuum of care by integrating clinical performance focused on promoting healing and reducing recovery time.
With the increasing use of advanced wound care in outpatient, long-term care, and home-based care settings, distributor representatives can now present RENCURA™ as a contract-supported solution. This offering aligns with provider priorities for improved outcomes, streamlined workflows, and standardized clinical protocols.
Building Supply Chain Confidence Through Stability and Scale
Supply reliability remains a primary concern for healthcare organizations amid ongoing volatility. A distinguishing feature of the Provista contract is Dukal’s ongoing commitment to supply chain resilience, supported by diversified sourcing strategies, expanded inventory, and proactive communication practices – core elements of Dukal’s InSight Supply Chain Solutions.
“We’re proud to contract with Provista to expand access to Dukal’s trusted wound care solutions,” said Charles Abbinanti, President of Dukal. “This agreement reflects our shared commitment to supporting healthcare professionals and strengthening family and community health.”
For distributors, this commitment provides more than contract eligibility. It instills confidence in continuity, stability, and the support of a partner dedicated to long-term performance.
Enabling Distributor Growth and Customer Success
With the Provista contract in place, Dukal is positioned to accelerate distributor growth strategies through:
- A broader portfolio spanning both traditional and advanced wound care
- Reliable supply chain backed by a resilient infrastructure
- Dedicated sales team committed to developing long-term partnerships
Establishing a robust platform for distributor sales teams to expand their wound care presence, enhance customer support, and assist providers in addressing the daily operational and clinical challenges we face today.